Innovative genetic tests for cancer prevention
Antegenes has raised €2.8M across 2 funding rounds from 3 investors, most recently a round in Aug 2022. Based in Tartu, Estonia; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2022-08-02 | Other | €2.3M | Enterprise Estonia,European Institute of Innovation and Technology | View deal → |
| 2021-11-10 | Other | €500k | Everything Genetic | View deal → |
